Biochemical identification of a mutated human melanoma antigen recognized by CD4+ T cells

Journal of Experimental Medicine

Volumn 189, Issue 5, 1999, Pages 757-765

  Pieper, Rembert ^a   Christian, Robert E ^b   Gonzales, Monica I ^a   Nishimura, Michael I ^a   Gupta, Gaorav ^a   Settlage, Robert E ^b   Shabanowitz, Jeffrey ^b   Rosenberg, Steven A ^a   Hunt, Donald F ^b   Topalian, Suzanne L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Antigen; CD4+ T cells; HLA DR1; Melanoma; Triosephosphate isomerase

Indexed keywords

CD4 ANTIGEN; TRIOSEPHOSPHATE ISOMERASE;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CHEMICAL ANALYSIS; GLYCOLYSIS; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MASS SPECTROMETRY; MELANOMA; MOLECULAR CLONING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; EPITOPES; HLA-DR1 ANTIGEN; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; TRIOSE-PHOSPHATE ISOMERASE;

EID: 0033103147     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.5.757     Document Type: Article

References (36)

1. Van Der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van Den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1643-1647.
2. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethé, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
3. Cox, A.L., J. Skipper, Y. Chen, R.A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, and C.L. Slingluff, Jr. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science. 264:716-719.
4. Robbins, P.F., and Y. Kawakami. 1996. Human tumor antigens recognized by T cells. Curr. Opin. Immunol. 8:628-636.
5. Rosenberg, S.A., J.C. Yang, D.J. Schwartzentruber, P. Hwu, F.M. Marincola, S.L. Topalian, N.P. Restifo, M.E. Dudley, S.L. Schwarz, P.J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321-327.
6. + T cell responses in antitumor immunity. Curr. Opin. Immunol. 10:588-594.
7. + T cells in cancer immunotherapy. Curr. Opin. Immunol. 6:741-745.
8. Topalian, S.L., L. Rivoltini, M. Mancini, N.R. Markus, P.F. Robbins, Y. Kawakami, and S.A. Rosenberg. 1994. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA. 91:9461-9465.
9. + T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J. Exp. Med. 183:1965-1971.
10. + T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int. J. Cancer. 58:69-79.
11. Monach, P.A., S.C. Meredith, C.T. Siegel, and H. Schreiber. 1995. A unique tumor antigen produced by a single amino acid substitution. Immunity. 2:45-59.
12. Topalian, S.L., L.M. Muul, D. Solomon, and S.A. Rosenberg. 1987. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods. 102:127-141.
13. Topalian, S.L., D. Solomon, and S.A. Rosenberg. 1989. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol. 142:3714-3725.
14. Yunis, J.J., H. Band, F. Bonneville, and E.J. Yunis. 1989. Differential expression of MHC class II antigens in myelomonocytic leukemia cell lines. Blood. 73:931-937.
15. Schwartzentruber, D.J., S.L. Topalian, M. Mancini, and S.A. Rosenberg. 1991. Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-α, and IFN-γ by human tumor-infiltrating lymphocytes after autologous tumor stimulation. J. Immunol. 146:3674-3681.
16. Eng, J., A.L. McCormack, and J.R. Yates III. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5:976-989.
17. Yates, J.R. III, J.K. Eng, A.L. McCormack, and D. Schieltz. 1995. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in a protein database. Anal. Chem. 8:1426-1436.
18. Schwartzentruber, D.J., S.S. Hom, R. Dadmarz, D.E. White, J.R. Yannelli, S.M. Steinberg, S.A. Rosenberg, and S.L. Topalian. 1994. In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2. J. Clin. Oncol. 12:1475-1483.
19. Stern, L.J., J.H. Brown, T.S. Jardetzky, J.C. Gorga, R.G. Urban, J.L. Strominger, and D.C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:215-221.
20. Rammensee, H.-G., T. Friede, and S. Stevanović. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:178-228.
21. Hill, C.M., A. Liu, K.W. Marshall, J. Mayer, B. Jorgensen, B. Yuan, R.M. Cubbon, E.A. Nichols, L.S. Wicker, and J.B. Rothbard. 1994. Exploration of requirements for peptide binding to HLA DRB1(Black star)0101 and DRB1(Black star)0401. J. Immunol. 152:2890-2898.
22. De Magistris, M.T., J. Alexander, M. Coggeshall, A. Altman, F.C.A. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68:625-634.
23. Alexander, J., K. Snoke, J. Ruppert, J. Sidney, M. Wall, S. Southwood, C. Oseroff, T. Arrhenius, F.C.A. Gaeta, S.M. Colón, H.M. Grey, and A. Sette. 1993. Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol. 150:1-7.
24. Yewdell, J.W., and J.R. Bennink. 1990. The binary logic of antigen processing and presentation to T cells. Cell. 62:203-206.
25. Knowles, J.R., and W.J. Albery. 1977. Perfection in enzyme catalysis: the energetics of triosephosphate isomerase. Accounts of Chemical Research. 10:105-111.
26. Ji, H., G.E. Reid, R.L. Moritz, J.S. Eddes, A.W. Burgess, and R.J. Simpson. 1997. A two-dimensional gel database of human colon carcinoma proteins. Electrophoresis. 18:605-613.
27. Clauser, K.R., S.C. Hall, D.M. Smith, J.W. Webb, L.E. Andrews, H.M. Tran, L.B. Epstein, and A.L. Burlingame. 1995. Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. Proc. Natl. Acad. Sci. USA. 92:5072-5076.
28. Rasmussen, R.K., H. Ji, J.S. Eddes, R.L. Moritz, G.E. Reid, R.J. Simpson, and D.S. Dorow. 1997. Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2. Electrophoresis. 18:588-598.
29. Perry, B.A., and H.W. Mohrenweiser. 1992. Human triosephosphate isomerase: substitution of Arg for Gly at position 122 in a thermolabile electromorph variant, TPI-Manchester. Hum. Genet. 88:634-638.
30. Brash, D.E., J.A. Rudolph, J.A. Simon, A. Lin, G.J. McKenna, H.P. Baden, A.J. Halperin, and J. Pontén. 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA. 88: 10124-10128.
31. INK4a-insensitive DCK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269:1281-1284.
32. Robbins, P.F., M. El-Gamil, Y.F. Li, Y. Kawakami, K. Loftus, E. Appella, and S.A. Rosenberg. 1996. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183:1185-1192.
33. Mande, S.C., V. Mainfroid, K.H. Kalk, K. Goraj, J.A. Martial, and W.G.J. Hol. 1994. Crystal structure of recombinant human triosephosphate isonierase at 2.8 Å resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme. Protein Sci. 3:810-821.
34. Blacklow, S.C., K.D. Liu, and J.R. Knowles. 1991. Stepwise improvements in catalytic effectiveness: independence and interdependence in combinations of point mutations of a sluggish triosephosphate isomerase. Biochemistry. 30:8470-8476.
35. Cormier, J.N., A. Abati, P. Fetsch, Y.M. Hijazi, S.A. Rosenberg, F.M. Marincola, and S.L. Topalian. 1998. Comparative analysis of the in vivo expression of tyrosinase, MART-1/ Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy. J. Immunother. 21:27-31.
36. + T lymphocytes. J. Interferon Cytokine Res. 15:739-746.